Profile
Ms. Loh Chin-Siew was formerly Head, Pharmaceuticals of the Biomedical Sciences Group at the Singapore Economic Development Board (EDB) where she was involved in developing strategies for the pharmaceuticals sector, and led the promotion efforts to encourage investments from global pharmaceutical companies.
Her principle areas of focus have been R&D and manufacturing, where she and her team successfully negotiated and secured several strategic investments in corporate R&D centres and manufacturing.
Ms. Loh completed her MBA at INSEAD in 2000.
At undergraduate level, she graduated with First Class Honours in Chemistry from the University of Bristol
Former positions of Loh Chin Siew
Companies | Position | End |
---|---|---|
ProTherapeutics Pte Ltd.
ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Director/Board Member | - |
Singapore Economic Development Board | Corporate Officer/Principal | - |
Bio*One Capital Pte Ltd.
Bio*One Capital Pte Ltd. Investment ManagersFinance Bio*One Capital Pte Ltd (Bio*One Capital) is a venture capital subsidiary of EDB Investments Pte Ltd founded in 1991. The firm is headquartered in Singapore. | Private Equity Investor | - |
Training of Loh Chin Siew
INSEAD | Masters Business Admin |
University of Bristol | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Bio*One Capital Pte Ltd.
Bio*One Capital Pte Ltd. Investment ManagersFinance Bio*One Capital Pte Ltd (Bio*One Capital) is a venture capital subsidiary of EDB Investments Pte Ltd founded in 1991. The firm is headquartered in Singapore. | Finance |
ProTherapeutics Pte Ltd.
ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Health Technology |
Singapore Economic Development Board | Government |
- Stock Market
- Insiders
- Loh Chin Siew